Global Non-Invasive Glucose Monitoring Market Report and Forecast 2024-2032

Non-Invasive Glucose Monitoring Market Size

The global non-invasive glucose monitoring market was valued at USD 182.1 million in 2023 driven by the rising prevalence of diabetes across the globe. The market is anticipated to grow at a CAGR of 8.3% during the forecast period of 2024-2032 to reach a value of USD 373.3 million by 2032. 

Non-Invasive Glucose Monitoring Market Outlook

• The market growth is driven by the rising prevalence of diabetes and obesity.

• The market is experiencing new product launches with advanced features, poised to improve patient outcomes in the coming years.

• North America is expected to lead the market share based on region, which can be attributed to a well-developed infrastructure and a higher diabetes prevalence.

Non-Invasive Glucose Monitoring Market Overview

Blood sugar monitoring is used to manage diabetes in patients with concerning blood sugar levels also known as hypoglycemia and hyperglycemia. Commonly used blood sugar monitoring devices include glucometers in which needles are used to prick the fingers of diabetic patients to draw blood samples. The non-invasive glucose monitoring devices have been witnessing high demand in the market as the traditional method leaves the patient’s health compromised with chances of infections. This painful procedure and the emphasis on preventing the chance of infection have been triggering the need for new developments in the domain.

Non-Invasive Glucose Monitoring Market Growth Drivers

Rising Prevalence of Diabetes Boosts Market Growth

The market growth can be attributed to the rising prevalence of diabetes across the globe. The growing geriatric population which is prone to the disease is further impacting the market value positively. According to the International Diabetes Federation, 537 million people around the world are living with diabetes. It was responsible for 6.7 million deaths in 2021. The IDF further highlighted that diabetes caused a whopping USD 966 billion worth of health expenditure globally. This is a 316% increase in comparison to the last 15 years.

New Product Launches to Meet Rising Non-Invasive Glucose Monitoring Market Demand

In January 2024, Samsung revealed its plan to add non-invasive blood sugar monitoring to its consumer health devices portfolio. As the trend around digitally advanced wearable healthcare devices is rising, market players are putting more effort into developing the latest and more powerful wearable devices. Hence, non-invasive glucose monitoring devices are expected to be more comfortable and accurate, boosting market growth in the forecast period.

Increasing Clinical Studies and Research Activities

The market growth is driven by rising clinical studies and trials. For instance, in March 2024, Know Labs, Inc., an emerging developer of non-invasive medical diagnostic technology, announced interim results from its most recent clinical research study. The study analysed the accuracy of Know Labs’ proprietary radiofrequency (RF) dielectric sensor in non-invasively measuring blood glucose in participants with prediabetes and Type 2 diabetes using venous blood as a comparative reference – resulting in an overall Mean Absolute Relative Difference (MARD) of 11.1%. The level of accuracy achieved by the radiofrequency (RF) dielectric sensor in measuring blood glucose non-invasively represents the rising adoption of such technologies in the coming years.

Moreover, in February 2024, Know Labs launched its KnowU device, a wearable, non-invasive continuous glucose monitor (CGM). The device is equipped with onboard computing power and machine learning capabilities in the presence of a unique and compact sensor that measures glucose levels via means of spectroscopy. Devices like knowU are also expected to be more cost-effective comparatively, thus propelling market growth.

Non-Invasive Glucose Monitoring Market Trends

The market is witnessing several trends and developments to improve the global current scenario. Some of the notable trends are as follows:

Non-Invasive Glucose Monitoring Market Segmentation

Market Breakup by Product Type

• Self-Monitoring Blood Glucose
  • Glucometer Devices
  • Test Strips
  • Lancets

• Continuous Glucose Monitoring
  • Sensors
  • Durables

Market Breakup by Site Outlook

• Arm/Wrist

• Ear Lobe

• Forefinger

• Thumb

• Others

Market Breakup by Application

• Intensive Insulin Therapy

• Hypoglycemia

• Diabetic Foot Ulcer Tracking

• Others

Market Breakup by End User

• Home Healthcare Setting

• Healthcare Provider

• Research Institutes

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Non-Invasive Glucose Monitoring Market Share

Segmentation by Application Dominating the Market Share

The market segmentation based on application includes intensive insulin therapy, hypoglycemia, diabetic foot ulcer tracking, and others. The market share is led by intensive insulin therapy due to the increasing prevalence of diabetes requiring constant monitoring and precise insulin management. Additionally, the trend toward personalised medicine further fuels the demand for non-invasive solutions that can provide continuous and reliable data, propelling market share growth.

Non-Invasive Glucose Monitoring Market Analysis by Region

North America leads the non-invasive glucose monitoring regional market due to the high prevalence of diabetes in the region. There is a substantial demand for innovative monitoring solutions, including non-invasive options. The regional dominance can be attributed to the presence of many leading medical device companies and research institutions, which are at the forefront of developing and commercialising advanced non-invasive glucose monitoring technologies.

The region has a robust healthcare infrastructure, coupled with high healthcare expenditure that supports the rapid adoption of new technologies. Additionally, the region is also experiencing heightened public awareness and acceptance of new healthcare technologies, driving the demand for non-invasive glucose monitoring solutions. The market share can also be attributed to the supportive government initiatives and reimbursement policies.

Leading players in the Global Non-Invasive Glucose Monitoring Market

The key features of the market report comprise patent analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:

Abbott Laboratories

Abbott Laboratories, established in 1888, is a global healthcare company headquartered in Abbott Park, Illinois, USA. The company specialises in the designing, manufacturing, and marketing of a wide range of medical products, including diagnostics, medical devices, and branded generic pharmaceuticals.

PHC Holdings Corporation

PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to society through healthcare solutions that have a positive impact and improve the lives of people.

Sanofi SA

Sanofi is a French multinational pharmaceutical and healthcare company focused on developing treatments for diabetes, cardiovascular diseases, rare diseases, multiple sclerosis, and vaccines. The company has major plans to enhance its capabilities in innovative diagnostic solutions.

Dexcom, Inc. 

DexCom, Inc. is a company focused on the development, manufacturing, production, and distribution of continuous glucose monitoring (CGM) systems for diabetes management.

Other key players in the market include DarioHealth Corp., Medtronic Plc., F. Hoffmann-La Roche Ltd, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care, and AgaMatrix Inc.

Key Highlights of the Report

Key Questions Answered in the Non-Invasive Glucose Monitoring Market

• What was the global non-invasive glucose monitoring market value in 2023? 
• What is the global non-invasive glucose monitoring market forecast outlook for 2024-2032? 
• What are the regional markets covered in the EMR report? 
• What is market segmentation based on product type? 
• How is the market segmented based on site outlook? 
• What is the market segmentation based on application?  
• Who are the end-users in the market? 
• What are the major factors aiding the non-invasive glucose monitoring market demand?  
• How has the market performed so far and how is it anticipated to perform in the coming years? 
• What are the market's major drivers, opportunities, and restraints?  
• Which regional market is expected to lead the market share in the forecast period?  
• Which country is expected to experience expedited growth during the forecast period?  
• What are the major non-invasive glucose monitoring market trends?
• Which site outlook is expected to dominate the market? 
• Which product type will dominate the market share?  
• Which end-user will lead the market?
• Who are the key players involved in the non-invasive glucose monitoring market? 
• What is the patent landscape of the market? 
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?